arrow
M

Marta Valenciano

epiconcept
H指数:33
被引数:3,572

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study

关于接种后时间对疫苗效力估计与报告的建议:一项COVID-19病例研究

2025-11-170
OA
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022

2021年10月2022年11月,在六个欧洲国家使用电子健康登记处监测新型冠状病毒肺炎疫苗对新型冠状病毒肺炎住院和死亡的有效性

2023-11-282
OAAI
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

疫苗对成人 (≥ 20岁) 在 α 和 δ 优势循环期间新型冠状病毒肺炎住院的有效性: I-MOVE-COVID-19和VEBIS SARI VE网络,欧洲,2021

2023-11-231
OAAI
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE- COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022

Omicron主导循环期间成人 (≥ 20岁) 新型冠状病毒肺炎住院的疫苗有效性: i-move新型冠状病毒肺炎和VEBIS SARI VE网络,欧洲,2022年2021

2023-11-236
OAAI
A pilot sentinel surveillance system to monitor treatment and treatment outcomes of chronic hepatitis B and C infections in clinical centres in three European countries, 2019
2023-02-093
OAAI
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study

欧洲流感疫苗对甲型流感亚型的有效性: 2021 2022的i-move初级保健多中心研究的结果

2022-11-2123
OA
SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
2022-08-2372
OAAI
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
2022-07-289
OAAI
Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned

2020年上半年在欧洲七个国家迅速调整初级保健哨点监测以新型冠状病毒肺炎: 优势,挑战和经验教训

2022-06-3017
OAAI
Transmission of SARS-CoV-2 in standardised first few X cases and household transmission investigations: A systematic review and meta-analysis
2022-06-169
OA
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021
2022-05-2618
OAAI
Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID-19 pandemic

早期流行病学调查: 世界卫生组织统一协议在新型冠状病毒肺炎大流行期间提供了一个标准化和及时的国际调查框架

2021-10-0540
OA
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021
2021-07-2235
OAAI
Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018
2021-01-2818
OAAI
Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020
2021-01-2217
OAAI
Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine

在实验室确诊的住院老年人中,针对A(H3N2) 和B流感的疫苗有效性,欧洲,2017-18: B谱系与三价疫苗不匹配的一个季节

2020-02-0521
OAAI
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort

欧洲15-64岁人群对甲型流感 (H3N2) 的低2018/19疫苗有效性: 按出生队列进行的探索

2019-11-2841
OAAI